Lastly, lysyl oxidase like-2 (LOXL2) showed promise in identifying early stages of RA-ILD, and its elevated levels were correlated with worsening pulmonary function tests, indicating its potential as a biomarker [25]. This evidence concerns the gene LOXL2 and rheumatoid arthritis.